| Members |
targetComponentId |
| Ceftazidime 1g powder for injection (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/25mL injection (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/vial injection (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 1g/vial powder (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime 2000mg infusion solution vial (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime 2g injection (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime 2g powder (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2g powder for infusion solution vial (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2g/vial injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 2gm/vil powder (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime 500mg infusion solution vial (product) |
Ceftazidime 500 mg powder for solution for injection vial |
| Ceftazidime 500mg injection (product) |
Ceftazidime 500 mg powder for solution for injection vial |
| Ceftazidime 500mg/vial injection (product) |
Ceftazidime 500 mg powder for solution for injection vial |
| Ceftazidime pentahydrate 100mg infusion solution vial (product) |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 1g injection (product) |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 1g/vial injection (product) |
Ceftazidime only product in parenteral dose form |
| Ceftazidime pentahydrate 2g injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime pentahydrate 2g powder for injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime pentahydrate 2g/vial injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime pentahydrate 6g infusion solution vial (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime pentahydrate 6g injection (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime pentahydrate 6g/vial injection (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 6 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 1g injection (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime sodium 1g powder for injection (product) |
Ceftazidime 1 g powder for solution for injection vial |
| Ceftazidime sodium 2g injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime sodium 2g powder for injection (product) |
Ceftazidime 2 g powder for solution for injection vial |
| Ceftazidime sodium 2g/50 mL conventional release solution for infusion 50mL bag |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 2g/50 mL injection (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 2g/50 mL intravenous solution 50mL bag (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftazidime sodium 2g/50mL injection (product) |
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Ceftizoxime sodium 10g powder for injection solution vial (product) |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftizoxime sodium 1g powder for injection solution vial (product) |
Product containing precisely ceftizoxime (as ceftizoxime sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ceftizoxime sodium 2g powder for injection solution vial (product) |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
| Ceftizoxime sodium 2g/vial injection (product) |
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial |
| Ceftizoxime sodium 500mg powder for injection solution vial (product) |
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial |
| Ceftriaxone sodium 10g powder for injection solution vial (product) |
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cefuroxime sodium 15mg/mL injection solution 50mL bag (product) |
Product containing precisely cefuroxime (as cefuroxime sodium) 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Cefuroxime sodium 30mg/mL injection solution 50mL bag (product) |
Cefuroxime (as cefuroxime sodium) 30 mg/mL solution for injection |
| Celecoxib (product) |
Celecoxib |
| Celluella pygmaea (organism) |
Callithrix pygmaea (organism) |
| Cellulitis of foot, except toe (disorder) |
Cellulitis of foot |
| Cellulitis of head, except face |
Cellulitis of head |
| Cellulomonas cellulans |
Cellulosimicrobium cellulans (organism) |
| Cellulomonas fermentans |
Actinotalea fermentans (organism) |
| Cellulose sodium phosphate 300g/bottle powder for oral suspension (product) |
Cellulose only product in oral dose form |
| Central cervical cord injury, without bony injury, C1-4 |
Central cervical cord injury, without spinal bony injury, C1-4 (disorder) |
| Central cervical cord injury, without bony injury, C5-7 |
Central cervical cord injury, without spinal bony injury, C5-7 (disorder) |
| Central respiratory stimulant (substance) |
stimulant respiratoire |
| Central venous catheter associated bloodstream infection |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
| Central venous catheter related bloodstream infection (disorder) |
Infection of bloodstream co-occurrent and due to central venous catheter in situ (disorder) |
| Centruroides sculpturatus (organism) |
Centruroides exilicauda |
| Cephalad pubic bone dysfunction (finding) |
Superior pubic shear (finding) |
| Cephalexin 125mg/5mL syrup (product) |
Cephalexin 25 mg/mL oral solution |
| Cephalexin 250mg/5mL syrup (product) |
Product containing precisely cefalexin anhydrous (as cefalexin) 50 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Cephalexin monohydrate 250mg capsule (product) |
Cephalexin 250 mg oral capsule |
| Cephalexin monohydrate 500mg capsule (product) |
Cephalexin 500 mg oral capsule |
| Cephalic presentation |
Cephalic fetal presentation |
| Cephalic version |
External cephalic version |
| Cephalophus doria (organism) |
Cephalophus zebra (organism) |
| Cephalotrichium |
Genus Strobilidium |
| Cephapirin sodium 1g powder for injection solution vial (product) |
Product containing precisely cefapirin (as cefapirin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Cercospora apii (organism) |
Mycocentrospora acerina |
| Cerebellar contusion with open intracranial wound and unspecified state of consciousness |
Cerebellar contusion with open intracranial wound |
| Cerebellar contusion without open intracranial wound and with unspecified state of consciousness (disorder) |
Cerebellar contusion without open intracranial wound (disorder) |
| Cerebellar laceration with open intracranial wound and unspecified state of consciousness (disorder) |
Cerebellar laceration with open intracranial wound |
| Cerebellar laceration without open intracranial wound and with unspecified state of consciousness (disorder) |
Cerebellar laceration without open intracranial wound |
| Cerebral degeneration (disorder) |
Degenerative brain disorder |
| Cerebral edema |
Cerebral edema |
| Cerebrocardiac neurosis |
Neurocirculatory asthenia |
| Cerebroretinal vasculopathy (disorder) |
Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations |
| Cerebrovascular accident annual review |
Cerebrovascular accident annual review |
| Certoparin sodium (product) |
Product containing certoparin (medicinal product) |
| Ceruloplasmin |
Ferroxidase |
| Cervical approach (qualifier value) |
Transcervical approach - uterine |
| Cervical flap |
Flap (substance) |
| Cervical region flap |
Flap (substance) |
| Cervical smear biopsy taken |
Sampling of cervix for Papanicolaou smear done (situation) |
| Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
| Cervical smear refused |
Screening for malignant neoplasm of cervix declined (situation) |
| Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
| Cervical spondylosis with myelopathy |
Myelopathy due to cervical spondylosis (disorder) |
| Cervical spondylosis with radiculopathy |
Radiculopathy due to cervical spondylosis (disorder) |
| Cervical syndrome, NEC (disorder) |
Cervical syndrome |
| Cervicitis (disorder) |
Cervicitis |
| Cervicohumeral fasciocutaneous flap |
Fasciocutaneous flap |
| Cervus elaphus bactrianus (organism) |
Cervus elaphus (organism) |
| Cervus elaphus nannodes (organism) |
Cervus elaphus (organism) |
| Cesarean delivery without indication |
Cesarean section |
| Cetirizine hydrochloride + pseudoephedrine 5mg/120mg m/r tablet (product) |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
| Cetirizine hydrochloride + pseudoephedrine 5mg/120mg prolonged-release oral tablet |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
| Cetirizine hydrochloride 5mg/5 mL syrup (product) |
Cetirizine hydrochloride 1 mg/mL oral solution |
| Cetirizine hydrochloride 5mg/5mL syrup (product) |
Cetirizine hydrochloride 1 mg/mL oral solution |
| Cetirizine hydrochloride+pseudoephedrine hydrochloride 5mg/120mg m/r tablet (product) |
Product containing only cetirizine and pseudoephedrine in oral dose form (medicinal product form) |
| Cetyl alcohol + colfosceril palmitate + tyloxapol 12mg/108mg/8mg powder (product) |
Product containing only cetyl alcohol and colfosceril and tyloxapol (medicinal product) |
| Cetyl dimethicone 5% bath oil (product) |
Cetyl dimethicone 50 mg/mL cutaneous oil |
| Challenging environment |
Challenging environment |
| Chamomile extracts 10.5% ointment (product) |
Product containing only chamomile extract (medicinal product) |
| Chancre of yaws (disorder) |
Initial lesion of yaws (disorder) |
| Chaperone refused |
Provision of chaperone declined |
| Chaperone refused |
Provision of chaperone declined |
| Chaperone refused (situation) |
Provision of chaperone declined |
FHIR